Masquer les AA |
Bloc 1 | Nombre d’heures de cours (*) | Pér. | Crédits | Pond. |
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | |
| Enseignements obligatoires communs | | | | | | | | 10 | |
| | | | | | | | | | |
| | UM-M1-BIOMED-016-M Rédaction et communication scientifique / Scientific Redaction & Communication | 15 | 0 | 220 | 0 | 0 | 235 | Q2 | 10 | 10 |
| | | M-DOYM-124 - Rédaction et communication scientifique / Scientific Redaction & Communication | | | | | | | | | |
| | | V-LANG-758 - Giving Scientific Presentations (preparatory workshops) | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements optionnels communs | | | | | | | | 26 | |
| | | | | | | | | | |
| | UM-M1-BIOMED-003-M Physiologie comparée | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-010 - Physiologie comparée | | | | | | | | | |
| | UM-M1-BIOMED-008-M Formation en expérimentation animale | 68 | 12 | 0 | 0 | 0 | 80 | Q1 | 8 | 8 |
| | | M-PHPH-003 - Formation en expérimentation animale | | | | | | | | | |
| | UM-M1-BIOMED-017-M Molecular & Cellular Biology of Cancer | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-004 - Molecular & Cellular Biology of Cancer | | | | | | | | | |
| | UM-M1-BIOMED-018-M Preclinical Models in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BIMO-028 - Preclinical Models in Cancerology | | | | | | | | | |
| | UM-M1-BIOMED-019-M Nuclear Receptor in Oncology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-023 - Nuclear Receptor in Oncology | | | | | | | | | |
| | UM-M1-BIOMED-020-M Eléments d'immunologie clinique et expérimentale | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-002 - Eléments d'immunologie clinique et expérimentale | | | | | | | | | |
| | UM-M1-BIOMED-021-M Histologie des organes des sens | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-HIST-003 - Histologie des organes des sens | | | | | | | | | |
| | | M-HIST-004 - Pathologies du système visuel | | | | | | | | | |
| | UM-M1-BIOMED-022-M Neuropharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-026 - Neuropharmacology | | | | | | | | | |
| | UM-M1-BIOMED-023-M Voies intracellulaires de communication et maladies métaboliques | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BHTO-005 - Voies intracellulaires de communication et maladies métaboliques | | | | | | | | | |
| | UM-M1-BIOMED-025-M Pharmacologie spéciale | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-042 - Pharmacologie spéciale | | | | | | | | | |
| | | M-DOYM-114 - Pharmacologie spéciale - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-026-M Méthodes de ciblage moléculaire et applications biomédicales de l'imagerie moléculaire | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-008 - Méthodes de ciblage en imagerie moléculaire et applications biomédicales de l'imagerie moléculaire | | | | | | | | | |
| | | M-CGOB-011 - Méthodes de ciblage en imagerie moléculaire et applications biomédicales de l'imagerie moléculaire - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-027-M Techniques d'imagerie médicale: principe et applications | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-009 - Techniques d'imagerie moléculaire: principe et applications | | | | | | | | | |
| | | M-CGOB-012 - Techniques d'imagerie médicale: principe et applications - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-028-M Integrative Biomedicine | 41 | 0 | 0 | 0 | 0 | 41 | Q1 | 6 | 6 |
| | | M-DOYM-117 - Brain & Immunity | | | | | | | | | |
| | | M-DOYM-118 - Brain -Gut axis- | | | | | | | | | |
| | | M-DOYM-119 - Neuro-endocrine System | | | | | | | | | |
| | | M-DOYM-120 - Neurovascular Unit & BBB | | | | | | | | | |
| | UM-M1-BIOMED-029-M Research Techniques in Neuroscience | 45 | 0 | 0 | 0 | 0 | 45 | Q1 | 6 | 6 |
| | | M-DOYM-122 - Research Techniques in Neuroscience | | | | | | | | | |
| | UM-M1-BIOMED-030-M Interdisciplinary Program in Healthcare Innovation | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 5 | 5 |
| | | M-PHPH-004 - Interdisciplinary Program in Healthcare Innovation | | | | | | | | | |
| | UM-M1-BIOMED-037-M Virologie | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | S-BIOG-156 - Virologie | | | | | | | | | |
| | UM-M1-BIOMED-038-M Tools to analyse brain function | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 |
| | | M-DOYM-050 - Tools to analyse brain function | | | | | | | | | |
| | UM-M1-BIOMED-040-M Introduction to Coding | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-NEUR-304 - Introduction to Coding | | | | | | | | | |
| | UM-M1-BIOMED-041-M Drugs & Strategies for Cancer Treatment | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-300 - Drugs & Strategies for Cancer Treatment - Part 1 | | | | | | | | | |
| | | M-ANBC-303 - Drugs & Strategies for Cancer Treatment - Part 2 | | | | | | | | | |
| | UM-M1-BIOMED-042-M Laboratory Methods in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-305 - Laboratory Methods in Cancerology | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements complémentaires dédiés aux étudiants "passerelles" | | | | | | | | 0 | |
| | | | | | | | | | |
| | UM-M1-BIOMED-024-M Neuroanatomie et sémiologie neurologique | 36 | 15 | 0 | 0 | 0 | 51 | Q1 | 4 | 4 |
| | | M-NEUR-301 - Neuroanatomie et sémiologie neurologique | | | | | | | | | |
| | UM-M1-BIOMED-013-M Anatomie pathologique générale | 20 | 10 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 |
| | | M-DOYM-040 - Anatomie pathologique générale | | | | | | | | | |
| | UM-M1-BIOMED-014-M Travaux personnels | 0 | 0 | 10 | 0 | 0 | 10 | Q1 | 5 | 5 |
| | | M-NEUR-111 - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-015-M Stage en laboratoire | 0 | 0 | 40 | 0 | 0 | 40 | Q1 | 5 | 5 |
| | | M-NEUR-112 - Stage en laboratoire | | | | | | | | | |
| | UM-M1-BIOMED-031-M Biochimie métabolique | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 |
| | | M-BIMO-201 - Biochimie métabolique | | | | | | | | | |
| | UM-M1-BIOMED-032-M Pharmacologie générale | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 2 | 2 |
| | | M-CTPH-303 - Pharmacologie générale | | | | | | | | | |
| | UM-M1-BIOMED-033-M Neurophysiologie des systèmes | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-NEUR-202 - Neurophysiologie des systèmes - Partie I | | | | | | | | | |
| | UM-M1-BIOMED-034-M Biologie moléculaire | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 3 | 3 |
| | | M-BIMO-204 - Biologie moléculaire | | | | | | | | | |
| | UM-M1-BIOMED-035-M Biologie cellulaire | 15 | 15 | 0 | 0 | 0 | 30 | Q2 | 2 | 2 |
| | | M-CGOB-302 - Biologie cellulaire | | | | | | | | | |
| | UM-M1-BIOMED-039-M Biochimie générale | 30 | 10 | 0 | 0 | 3 | 43 | Q2 | 4 | 4 |
| | | M-BIMO-101 - Biochimie générale | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements obligatoires spécifiques à la finalité approfondie | | | | | | | | 24 | |
| | | | | | | | | | |
| | UM-M1-BIOMFA-019-M Biologie intégrée - Aspects théoriques et pratiques | 35 | 40 | 0 | 0 | 0 | 75 | Q1,Q2 | 6 | 6 |
| | | S-BIOG-078 - Biologie intégrée (génomique, protéomique, métabonomique) | | | | | | | | | |
| | | M-DOYM-041 - Bioinformatique | | | | | | | | | |
| | | M-BIMO-004 - Analyses intégratives de données variées | | | | | | | | | |
| | | M-DOYM-043 - Biostatistique | | | | | | | | | |
| | UM-M1-BIOMFA-021-M Complément de biologie cellulaire | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-CGOB-010 - Complément de biologie cellulaire | | | | | | | | | |
| | UM-M1-BIOMFA-022-M Protéomie structurale et fonctionnelle | 20 | 0 | 20 | 0 | 0 | 40 | Q1,Q2 | 3 | 3 |
| | | S-BIOG-057 - Protéomie structurale et fonctionnelle (Partie A) | | | | | | | | | |
| | | M-DOYM-111 - Protéomie structurale et fonctionnelle - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMFA-023-M Thérapie génique: de la biologie moléculaire aux nouveaux médicaments personnalisés | 20 | 10 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 |
| | | M-BIMO-005 - Les acides nucléiques, nouvelle source de thérapie personnalisée | | | | | | | | | |
| | | M-BIMO-003 - Thérapie génique: de la biologie moléculaire aux nouveaux médicaments personnalisés | | | | | | | | | |
| | UM-M1-BIOMFA-024-M Formation expérimentale au doctorat (3 mois) | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 10 | 10 |
| | | M-DOYM-033 - Stage de préparation au mémoire | | | | | | | | | |
| | | M-DOYM-036 - Préparation technique au mémoire | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | 60 | |
| | | | | | | | | |
Bloc 2 | Nombre d’heures de cours (*) | Pér. | Crédits | Pond. |
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | |
| Enseignements obligatoires communs | | | | | | | | 40 | |
| | | | | | | | | | |
| | UM-M2-BIOMED-007-M Mémoire / Master Thesis | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 19 | 19 |
| | | M-DOYM-049 - Mémoire / Master Thesis | | | | | | | | | |
| | UM-M2-BIOMED-008-M Stage extérieur / External Training | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 21 | 21 |
| | | M-DOYM-035 - Stage extérieur / External Training | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements optionnels communs | | | | | | | | 14 | |
| | | | | | | | | | |
| | UM-M2-BIOMED-001-M GMP-GLP-Validation | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-012 - GMP-GLP-Validation | | | | | | | | | |
| | UM-M2-BIOMED-002-M Propriété intellectuelle | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-003 - Propriété intellectuelle | | | | | | | | | |
| | UM-M2-BIOMED-003-M Sensibilisation à la gestion de projets d'innovation technologique | 32 | 0 | 10 | 0 | 0 | 42 | Q1,Q2 | 4 | 4 |
| | | M-DOYM-034 - Sensibilisation à la gestion de projets d'innovation technologique | | | | | | | | | |
| | | M-DOYM-115 - Sensibilisation à la gestion de projets d'innovation technologique - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-011-M Neurotoxicology and Safety Pharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-129 - Neurotoxicology and Safety Pharmacology | | | | | | | | | |
| | UM-M2-BIOMED-012-M Molecular & Cellular Biology of Cancer | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-004 - Molecular & Cellular Biology of Cancer | | | | | | | | | |
| | UM-M2-BIOMED-013-M Preclinical Models in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BIMO-028 - Preclinical Models in Cancerology | | | | | | | | | |
| | UM-M2-BIOMED-014-M Nuclear Receptor in Oncology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-023 - Nuclear Receptor in Oncology | | | | | | | | | |
| | UM-M2-BIOMED-015-M Eléments d'immunologie clinique et expérimentale | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-002 - Eléments d'immunologie clinique et expérimentale | | | | | | | | | |
| | UM-M2-BIOMED-016-M Histologie des organes des sens | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-HIST-003 - Histologie des organes des sens | | | | | | | | | |
| | | M-HIST-004 - Pathologies du système visuel | | | | | | | | | |
| | UM-M2-BIOMED-017-M Neuropharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-026 - Neuropharmacology | | | | | | | | | |
| | UM-M2-BIOMED-018-M Voies intracellulaires de communication et maladies métaboliques | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BHTO-005 - Voies intracellulaires de communication et maladies métaboliques | | | | | | | | | |
| | UM-M2-BIOMED-019-M Pharmacologie spéciale | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-042 - Pharmacologie spéciale | | | | | | | | | |
| | | M-DOYM-114 - Pharmacologie spéciale - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-020-M Méthodes de ciblage moléculaire et applications biomédicales de l'imagerie moléculaire | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-008 - Méthodes de ciblage en imagerie moléculaire et applications biomédicales de l'imagerie moléculaire | | | | | | | | | |
| | | M-CGOB-011 - Méthodes de ciblage en imagerie moléculaire et applications biomédicales de l'imagerie moléculaire - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-021-M Techniques d'imagerie médicale: principe et applications | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-009 - Techniques d'imagerie moléculaire: principe et applications | | | | | | | | | |
| | | M-CGOB-012 - Techniques d'imagerie médicale: principe et applications - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-022-M Integrative Biomedicine | 41 | 0 | 0 | 0 | 0 | 41 | Q1 | 6 | 6 |
| | | M-DOYM-117 - Brain & Immunity | | | | | | | | | |
| | | M-DOYM-118 - Brain -Gut axis- | | | | | | | | | |
| | | M-DOYM-119 - Neuro-endocrine System | | | | | | | | | |
| | | M-DOYM-120 - Neurovascular Unit & BBB | | | | | | | | | |
| | UM-M2-BIOMED-023-M Research Techniques in Neuroscience | 45 | 0 | 0 | 0 | 0 | 45 | Q1 | 6 | 6 |
| | | M-DOYM-122 - Research Techniques in Neuroscience | | | | | | | | | |
| | UM-M2-BIOMED-026-M Virologie | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | S-BIOG-156 - Virologie | | | | | | | | | |
| | UM-M2-BIOMED-027-M Tools to analyse brain function | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 |
| | | M-DOYM-050 - Tools to analyse brain function | | | | | | | | | |
| | UM-M2-BIOMED-028-M Introduction to Computational Neuroscience | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 3 | 3 |
| | | M-DOYM-065 - Introduction to Computational Neuroscience | | | | | | | | | |
| | UM-M2-BIOMED-029-M Basic Understanding of AI and BCI | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-066 - Basic Understanding of AI and BCI | | | | | | | | | |
| | UM-M2-BIOMED-030-M Introduction to Coding | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-NEUR-304 - Introduction to Coding | | | | | | | | | |
| | UM-M2-BIOMED-031-M Drugs & Strategies for Cancer Treatment | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-300 - Drugs & Strategies for Cancer Treatment - Part 1 | | | | | | | | | |
| | | M-ANBC-303 - Drugs & Strategies for Cancer Treatment - Part 2 | | | | | | | | | |
| | UM-M2-BIOMED-032-M Laboratory Methods in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-305 - Laboratory Methods in Cancerology | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements obligatoires spécifiques à la finalité approfondie | | | | | | | | 6 | |
| | | | | | | | | | |
| | UM-M2-BIOMFA-001-M Approche transdisciplinaire des problèmes biomédicaux | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-048 - Approche transdisciplinaire des problèmes biomédicaux | | | | | | | | | |
| | | M-DOYM-112 - Approche transdisciplinaire des problèmes biomédicaux - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMFA-002-M Évaluation du risque, étude d'impact sanitaire | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 2 | 2 |
| | | M-BHTO-002 - Etude d'impact sanitaire | | | | | | | | | |
| | | M-BHTO-111 - Risques hospitaliers | | | | | | | | | |
| | UM-M2-BIOMFA-003-M Vaccinologie | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-004 - Vaccinologie | | | | | | | | | |
| | | M-DOYM-116 - Vaccinologie - Travaux personnels | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | 60 | |
| | | | | | | | | |